Nyah M
A
BREAKING: After facing intense pressure from the Biden Administration, drug maker Boehringer Ingelheim will cap out-of-pocket costs for all its inhalers at $35 per month. That will dramatically reduce costs for the most vulnerable patients—including the uninsured or underinsured.

Thanks Brandon!
10:32 PM - Mar 18, 2024
Avatar Avatar Avatar
0
1
27
Susan McBride
A
In response to Nyah M.
10:51 PM - Mar 18, 2024
0
2

 

{{ notificationModalContent }} {{ promptModalMessage }}